Albaugh, LLC and Italpollina USA, Inc. recently announced a long-term strategic collaboration to deliver microbial seed treatment solutions for the US Seed Treatment Market. In the agreement, Albaugh, LLC will have the exclusive rights to develop, commercialize and distribute Italpollina seed treatment technology in the US.
Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, has recently acquired Arysta LifeScience Limited ("Arysta"), a leading global provider of crop solutions with expertise in agrochemical and biological products, from a company backed by the Permira funds for approximately $3.51 billion, subject to regulatory approval.
Yara International ASA has obtained relevant regulatory approvals and closed the acquisition of OFD Holding Inc. (OFD) allowing the integration process to start.
The OFD operations comprise production facilities in Cartagena, Colombia and distribution companies across Latin America.
Tessenderlo Group (Belgium) and TETRA Chemicals Europe AB (a subsidiary of TETRA Technologies, Inc.) signed a long term agreement with regard to the production and marketing of calcium chloride. Tessenderlo Group will build a new calcium chloride production plant on its site in Ham, Belgium and TETRA Chemicals will market the product. The agreement will allow both parties to strengthen their respective global positions as market leaders in calcium chloride (TETRA Chemicals) and potassium sulfate (Tessenderlo Group).
The market for slow- and controlled-release and stabilized fertilizers develops at sustained pace. Traditionally, these products have mainly been applied to specialty crops. However, they increase progressively their market share in the broad acre crop sector (maize in the United States and rice in Japan and China but also on other crops in other regions). How is this market expected to evolve in the medium- to long-term? What will be the key drivers of the growth: product development, economics or policy environment? How can the constraints to their wider use be alleviated?